ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

UBS Group AG's Holding History (CIK: 0001610520)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 670 Value ($000) $1 Avg Close — Range —
Q3 2025
Shares 670 Value ($000) $1 Avg Close — Range —
Q2 2025
Shares 330 Value ($000) $0 Avg Close — Range —
Q1 2025
Shares 330 Value ($000) $0 Avg Close — Range —